For the first time, researchers have described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1NFGqSs
from Today's Healthcare News -- ScienceDaily http://ift.tt/1NFGqSs
No comments:
Post a Comment